Research Article
The Design and Construction of K11: A Novel α-Helical Antimicrobial Peptide
Table 5
MICs of K11 for clinically isolated bacteria.
| Bacteria | MIC (μg/mL) |
| MRSA (5) | 0.25−4 | Pseudomonas aeruginosa (4) | 1.0−8.0 | Staphylococcus epidermidis (3) | 0.5−8 | Klebsiella pneumonia (6) | 0.5−4.0 |
|
|